Further studies are needed to investigate IL-23R polymorphisms in serum and skin lesions together with IL-17 levels and to evaluate more candidate IL-23R gene polymorphisms in larger groups of patients with psoriasis. This evidence concerns the gene IL23R and psoriasis.